BRIEF-Valeant seeing 'anxiety' among US staff, will expand retention program - spokeswoman
Nov 18 (Reuters) - Valeant Pharmaceuticals International Inc
* Likely to make tuck-in acquisitions, but debt repayment the focus - spokeswoman
* On track to meeting Salix inventory goal
* Spokeswoman speaking at London health care conference Further company coverage: (Reporting By Rod Nickel)
© Thomson Reuters 2017 All rights reserved.